文献速递母胎医学妇科

产前cfDNA筛查结果提示母体肿瘤:当前实践与管理需求调查

Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs.
PubMed 文献 · Prenat Diagn · 2016-12-16

通过美国国家遗传咨询师协会招募遗传咨询师进行问卷调查,超过300名咨询师参与。95%知晓无创产前检测(NIPT)结果可能提示母体肿瘤,77%会告知该结果,但仅29%在检测前常规告知患者这一可能性。管理建议差异大,51.8%对咨询此类患者感到不适,91.3%认为需要机构或国家指南。

要点

  • 95%的遗传咨询师知晓NIPT结果可能提示母体肿瘤,77%会告知该结果。
  • 仅29%在检测前常规告知患者NIPT可能提示母体肿瘤。
  • 91.3%的咨询师认为需要机构或国家指南来管理此类患者。

核心结论

  • 多数遗传咨询师对咨询产前cfDNA结果提示母体肿瘤的患者既未感到装备充分也不感到舒适。
  • 本研究显示需要临床医生、研究人员和实验室合作发表关于NIPT结果提示母体肿瘤的数据,并制定管理指南。

研究设计与样本

  • 通过美国国家遗传咨询师协会(NSGC)招募遗传咨询师完成问卷调查,超过300名遗传咨询师参与。

主要发现

  • 95%的参与者知晓无创产前检测(NIPT)结果可能提示母体肿瘤,77%报告会告知该结果。
  • 仅29%在检测前常规告知患者NIPT可能提示母体肿瘤。
  • 咨询师给出的管理建议高度可变,51.8%表示咨询此类患者感到不适或非常不适。
  • 44.3%认为NIPT提示母体肿瘤的当前获益大于潜在危害,80.2%认为未来会有益。
  • 91.3%认为需要机构或国家指南来管理患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine genetic counselors' current practices and management needs for patients with prenatal cfDNA screening results indicative of maternal neoplasm. METHODS: A survey was completed by genetic counselors recruited via the National Society of Genetic Counselors (NSGC). RESULTS: Over 300 genetic counselors were surveyed. Almost all participants (95%) were aware that Noninvasive Prenatal Testing (NIPT) results may suggest maternal neoplasm, and 77% reported they would disclose such results. However, only 29% routinely communicate this possibility to patients in a pre-test setting. Management recommendations made by counselors were highly variable, and over half (51.8%) stated they would feel uncomfortable or very uncomfortable counseling a patient with these results. While less than half (44.3%) believed the current benefits of NIPT's ability to suggest maternal neoplasm outweigh its potential harms, 80.2% recognized it would be beneficial in the future. A vast majority of counselors (91.3%) felt institutional or national guidelines were needed for patient management. CONCLUSION: A majority of counselors neither felt properly equipped nor comfortable counseling patients with prenatal cfDNA results suggestive of maternal neoplasm. This study demonstrates a need for collaboration amongst clinicians, researchers, and laboratories to publish data regarding NIPT results indicative of maternal neoplasm, and for the creation of management guidelines. © 2016 John Wiley & Sons, Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Giles ME, Murphy L, Krstić N, et al. Prenatal cfDNA screening results indicative of maternal neoplasm: survey of current practice and management needs. Prenat Diagn. 2016. PMID: 27878832. doi:10.1002/pd.4973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。